CompletedPhase 3

Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

South Korea170 participantsStarted 2019-04-10

Plain-language summary

Age range20 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. A man or woman who has experienced symptom(hearburn or/and acid regurgitation) over 3month at least.
✓. A man or woman who has experienced symptom(heartburn or/and acid regurgitation) within 7days before Visit1, meet below 1) or 2) criteria.
✓. A man or woman who has been made diagnosis as LA grade0(Zero) measured through the dendoscopy which is corried out within 14 days, there is no observed muscosal break.

Recovered percentage(%) of the symptom

Timeframe: within 4 weeks

Change of the score about the symptom

Timeframe: within 4 weeks

Percentage(%) of the patients who have symptom during the daytime

Timeframe: within 4 weeks

Percentage(%) of the patients who have symptom during the nighttime

Timeframe: within 4 weeks

Percentage(%) of the days no symtom

Timeframe: within 4 weeks

NCT IDNCT03967886

SponsorYooyoung Pharmaceutical Co., Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2019-12-20